These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Nutritional treatment for acquired immunodeficiency virus infection using an enterotropic peptide-based formula enriched with n-3 fatty acids: a randomized prospective trial. de Luis Román DA, Bachiller P, Izaola O, Romero E, Martin J, Arranz M, Eiros Bouza JM, Aller R. Eur J Clin Nutr; 2001 Dec; 55(12):1048-52. PubMed ID: 11781670 [Abstract] [Full Text] [Related]
5. High-energy, high-protein, oral, liquid, nutrition supplementation in patients with HIV infection: effect on weight status in relation to incidence of secondary infection. Stack JA, Bell SJ, Burke PA, Forse RA. J Am Diet Assoc; 1996 Apr; 96(4):337-41. PubMed ID: 8598433 [Abstract] [Full Text] [Related]
6. Soluble tumor necrosis factor receptors as surrogate markers for the assessment of zidovudine treatment in asymptomatic HIV-1 infection. Godfried MH, van der Poll T, Mulder JW, Weverling GJ, Endert E, Lange JM, Sauerwein HP. J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec 15; 10(5):531-9. PubMed ID: 8548332 [Abstract] [Full Text] [Related]
7. Growth, efficacy, and safety of feeding an iron-fortified human milk fortifier. Berseth CL, Van Aerde JE, Gross S, Stolz SI, Harris CL, Hansen JW. Pediatrics; 2004 Dec 15; 114(6):e699-706. PubMed ID: 15545616 [Abstract] [Full Text] [Related]
10. [Serial assessment of the nutritional status of patients infected by the human immunodeficiency virus. Role of tumor necrosis factor/its receptors]. Segura Fernández E, Domenech Cienfuegos I, Pérez Guzmán E, Guerrero Sánchez F, Escribano Moriana JC, Pérez Cano R, Fernández-Gutiérrez del Alamo C, Girón González JA. Rev Clin Esp; 1999 Dec 15; 199(12):790-5. PubMed ID: 10687411 [Abstract] [Full Text] [Related]
11. US youths in the early stages of HIV disease have low intakes of some micronutrients important for optimal immune function. Kruzich LA, Marquis GS, Carriquiry AL, Wilson CM, Stephensen CB. J Am Diet Assoc; 2004 Jul 15; 104(7):1095-101. PubMed ID: 15215767 [Abstract] [Full Text] [Related]
12. A randomized double-blind controlled study of 6 months of oral nutritional supplementation with arginine and omega-3 fatty acids in HIV-infected patients. Swiss HIV Cohort Study. Pichard C, Sudre P, Karsegard V, Yerly S, Slosman DO, Delley V, Perrin L, Hirschel B. AIDS; 1998 Jan 01; 12(1):53-63. PubMed ID: 9456255 [Abstract] [Full Text] [Related]
13. Long-term effects of early nutritional support with new enterotropic peptide-based formula vs. standard enteral formula in HIV-infected patients: randomized prospective trial. Chlebowski RT, Beall G, Grosvenor M, Lillington L, Weintraub N, Ambler C, Richards EW, Abbruzzese BC, McCamish MA, Cope FO. Nutrition; 1993 Jan 01; 9(6):507-12. PubMed ID: 8111140 [Abstract] [Full Text] [Related]
14. Metabolic and immune effects of dietary arginine, glutamine and omega-3 fatty acids supplementation in immunocompromised patients. Chuntrasakul C, Siltharm S, Sarasombath S, Sittapairochana C, Leowattana W, Chockvivatanavanit S, Bunnak A. J Med Assoc Thai; 1998 May 01; 81(5):334-43. PubMed ID: 9623033 [Abstract] [Full Text] [Related]
18. The use of novel foods enriched with long-chain n-3 fatty acids to increase dietary intake: a comparison of methodologies assessing nutrient intake. Patch CS, Tapsell LC, Mori TA, Meyer BJ, Murphy KJ, Mansour J, Noakes M, Clifton PM, Puddey IB, Beilin LJ, Annison G, Howe PR. J Am Diet Assoc; 2005 Dec 01; 105(12):1918-26. PubMed ID: 16321598 [Abstract] [Full Text] [Related]